Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc has demonstrated significant financial growth, reporting record total revenues of $12.1 million for the quarter, which is a 154% year-over-year increase and exceeds consensus estimates. The company's robust performance is attributed to an increase in the average selling price due to a higher volume of Medicare patients and a 106% year-over-year rise in total revenue units. Furthermore, with management anticipating total revenues to reach between $50 million and $53 million in 2025, along with a gross margin improvement to 71%, the company indicates strong operational momentum and a positive trajectory for future financial performance.

Bears say

Myomo Inc's reported backlog of insurance-authorized orders decreased to 272 from 316 in the previous quarter, indicating a potential decline in demand or sales pipeline. The company faces multiple significant risks including balance sheet and liquidity challenges, regulatory hurdles, and uncertainties surrounding product commercialization and reimbursement processes. Despite a net loss of $0.01 per share—slightly better than the consensus estimate—the overall sentiment remains negative due to these operational and market risks, weighing heavily on the company’s financial health and future prospects.

Myomo (MYO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.52, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.52, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.